# Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

> **NCT02933658** · PHASE1 · COMPLETED · sponsor: **Daewon Pharmaceutical Co., Ltd.** · enrollment: 71 (actual)

## Conditions studied

- Hypertension and Dyslipidemia

## Interventions

- **DRUG:** Telmisartan
- **DRUG:** Amlodipine
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT02933658
- **Lead sponsor:** Daewon Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2015-11
- **Final completion:** —
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2016-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933658, "Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02933658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*